ST Pharm is a global API CDMO headquartered in South Korea that offers technology-driven gene therapy development and manufacturing services, from oligonucleotides to xRNA. The company has fully integrated oligonucleotide and mRNA solutions, supplying nucleoside-APIs for global pharma developers while also offering custom development and manufacturing services. ST Pharm develops mRNA vaccines and therapeutics with its core capping technology and mRNA–LNP platform. Their services include IVT mRNA synthesis, purification, GMP manufacturing, and CMC and regulatory support. With facilities in South Korea, the U.S., Spain, and Switzerland, ST Pharm has a true global presence.